
Daily Derm Times: March 13, 2025
Key Takeaways
- COVID-19 has reshaped dermatology through telehealth, social media, and increased cosmetic procedures, presenting ongoing challenges and opportunities.
- New biomarker tests for inflammatory skin diseases enable more personalized and effective treatment options for conditions like psoriasis and atopic dermatitis.
Catch up on dermatology news, highlights, and insights from the past 24 hours.
To stay up-to-date with the latest dermatology news, sign up to receive our
Reshaping Dermatology: The Enduring Impact of COVID-19
The COVID-19 pandemic reshaped dermatology through telehealth, social media, and increased cosmetic procedures. Challenges and opportunities persist as practices adapt.
New Biomarker Test Revolutionizes Inflammatory Skin Disease Diagnosis
By leveraging the innovative biomarker panels, clinicians can now offer more personalized and effective treatment options for psoriasis and AD.
Celebrating Second Annual National Dermatologist Day with Launch of EltaMD’s ‘Derm Difference’ Campaign
EltaMD’s Derm Difference campaign honors dermatologists’ expertise in skin health, cancer prevention, and confidence-boosting care.
Novel Acne Scar Gel Has High Rates of Efficacy and Patient Satisfaction
A majority of patients noticed improvement in hyperpigmentation spots, skin texture and evenness after 12 weeks of use.
National Eczema Association Expands Visual Guide to Address Skin Tone Disparities
Wendy Smith Begolka, MBS, and Renata Block, MMS, PA-C discuss the NEA's expanded eczema visual guide and upcoming Chicago event to support diverse patient communities.
Mohs Surgery Outperforms Wide Local Excision in SCC Control
An analysis of 70 studies shows that MMS reduces local recurrence to 5.0% compared to 17.7% for WLE in anogenital SCC cases.
Monica K. Li, MD: Global Innovations, Integration with Other Modalities, and Future Trends in Microneedling
Li discusses microneedling innovations, global techniques, safety, and future trends in dermatology, including integration with RF and PRP.
Mastering Dermoscopy and Dysplastic Nevi
Elizabeth Berry, MD, FAAD, reviewed dysplastic nevi as risk markers and highlighted the need for more data on severe cases at AAD 2025.
Information Related to Diet and Psoriasis on Instagram is Unreliable, According to New Analysis
99% of posts on the platform were of poor quality, according to the DISCERN instrument.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















